PRICE T ROWE ASSOCIATES INC /MD/ - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$214,000
-99.5%
9,200
-99.5%
0.00%
-100.0%
Q3 2016$42,248,000
+41.7%
1,722,415
+16.1%
0.01%
+33.3%
Q2 2016$29,818,000
-47.3%
1,483,154
-31.0%
0.01%
-50.0%
Q1 2016$56,530,000
-97.5%
2,148,801
-90.2%
0.01%
-97.4%
Q4 2015$2,220,949,000
-37.9%
21,853,814
+9.0%
0.47%
-41.3%
Q3 2015$3,575,389,000
-21.3%
20,046,911
-2.0%
0.80%
-14.9%
Q2 2015$4,545,817,000
+13.7%
20,463,632
+1.7%
0.94%
+13.3%
Q1 2015$3,996,423,000
+56.5%
20,125,336
+12.8%
0.82%
+52.2%
Q4 2014$2,553,779,000
+11.2%
17,842,284
+2.0%
0.54%
+8.2%
Q3 2014$2,295,728,000
+10.6%
17,497,210
+6.3%
0.50%
+11.6%
Q2 2014$2,075,927,000
+12.0%
16,455,707
+17.1%
0.45%
+7.9%
Q1 2014$1,853,049,000
-46.6%
14,056,827
-52.5%
0.42%
+4.5%
Q4 2013$3,470,964,000
+114.6%
29,567,206
+90.7%
0.40%
-1.5%
Q3 2013$1,617,735,000
-39.3%
15,504,335
-50.0%
0.40%
+13.2%
Q2 2013$2,666,712,00030,982,5400.36%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q2 2018
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders